Emerging therapeutic strategies for transplantation-induced acute kidney injury: protecting the organelles and the vascular bed

References

• Chawla LS, Bellomo R, Bihorac A, et al. Acute kidney disease and renal recovery: consensus report of the Acute Disease Quality Initiative (ADQI) 16 Workgroup. Nat Rev Nephrol. 2017;13:241–257.
   PubMed Web of Science ®Google Scholar
• Husain-Syed F, Ronco C. The odyssey of risk stratification in acute kidney injury. Nat Rev Nephrol. 2018;14:660–662.
   PubMed Web of Science ®Google Scholar
• Pereira M, Rodrigues N, Godinho I, et al. Acute kidney injury in patients with severe sepsis or septic shock: a comparison between the “Risk, Injury, Failure, Loss of kidney function, End-stage kidney disease” (RIFLE), Acute Kidney Injury Network (AKIN) and Kidney Disease: improving Global Outcomes (KDIGO) classifications. Clin Kidney J. 2017;10:332–340.
   PubMed Web of Science ®Google Scholar
• Zuk A, Bonventre JV. Acute Kidney Injury. Annu Rev Med. 2016;67:293–307.
   PubMed Web of Science ®Google Scholar
• Ow CPC, Ngo JP, Ullah MM, et al. Renal hypoxia in kidney disease: cause or consequence? Acta Physiol Oxf Eng. 2018;222:e12999.
   PubMed Web of Science ®Google Scholar
• Favreau F, Giraud S, Bon D, et al. (Ischemia reperfusion control: the key of kidney graft outcome). Méd Sci MS. 2013;29:183–188.
   Google Scholar
• Le Pape S, Pasini-Chabot O, Couturier P, et al. Decoding cold ischaemia time impact on kidney graft: the kinetics of the unfolded protein response pathways. Artif Cells Nanomed Biotechnol. 2018;1–13. doi:10.1080/21691401.2018.1518908.
   Web of Science ®Google Scholar
• Giraud S, Steichen C, Allain G, et al. Dynamic transcriptomic analysis of ischemic injury in a porcine pre-clinical model mimicking donors deceased after circulatory death. Sci Rep. 2018;8:5986.
   PubMed Web of Science ®Google Scholar
• Russo MJ, Chen JM, Sorabella RA, et al. The effect of ischemic time on survival after heart transplantation varies by donor age: an analysis of the united network for organ sharing database. J Thorac Cardiovasc Surg. 2007;133:554–559.
   PubMed Web of Science ®Google Scholar
• Patel ND, Weiss ES, Nwakanma LU, et al. Impact of donor-to-recipient weight ratio on survival after heart transplantation analysis of the united network for organ sharing database. Circulation. 2008;118:S83–8.
   PubMed Web of Science ®Google Scholar
• Morizane R, Miyoshi T, Bonventre JV. Concise review: kidney generation with human pluripotent stem cells. Stem Cells Dayt Ohio. 2017;35:2209–2217.
   PubMedGoogle Scholar
• Okouchi Y, Sasaki K, Tamaki T. Ultrastructural changes in hepatocytes, sinusoidal endothelial cells and macrophages in hypothermic preservation of the rat liver with university of Wisconsin solution. Virchows Arch Int J Pathol. 1994;424:477–484.
   PubMed Web of Science ®Google Scholar
• Mosbah IB, Zaouali MA, Martel C, et al. IGL-1 solution reduces endoplasmic reticulum stress and apoptosis in rat liver transplantation. Cell Death Dis. 2012;3:e279.
   PubMed Web of Science ®Google Scholar
• Fougeray S, Bouvier N, Beaune P, et al. Metabolic stress promotes renal tubular inflammation by triggering the unfolded protein response. Cell Death Dis. 2011;2:e143.
   PubMedGoogle Scholar
• Hetz C, Chevet E, Harding HP. Targeting the unfolded protein response in disease. Nat Rev Drug Discov. 2013;12:703–719.
   PubMed Web of Science ®Google Scholar
• Ron D, Walter P. Signal integration in the endoplasmic reticulum unfolded protein response. Nat Rev Mol Cell Biol. 2007;8:519–529.
   PubMed Web of Science ®Google Scholar
• Jonikas MC, Collins SR, Denic V, et al. Comprehensive characterization of genes required for protein folding in the endoplasmic reticulum. Science. 2009;323:1693–1697.
   PubMed Web of Science ®Google Scholar
• Ameri K, Harris AL. Activating transcription factor 4. Int J Biochem Cell Biol. 2008;40:14–21.
   PubMed Web of Science ®Google Scholar
• Hetz C, Glimcher LH. Fine-tuning of the unfolded protein response: assembling the IRE1α interactome. Mol Cell. 2009;35:551–561.
   PubMed Web of Science ®Google Scholar
• Hollien J, Weissman JS. Decay of endoplasmic reticulum-localized mrnas during the unfolded protein response. Science. 2006;313:104–107.
   PubMed Web of Science ®Google Scholar
• Upton J-P, Wang L, Han D, et al. IRE1α cleaves select microRNAs during ER stress to derepress translation of proapoptotic caspase-2. Science. 2012;338:818–822.
   PubMed Web of Science ®Google Scholar
• Jackson RJ, Hellen CUT, Pestova TV. The mechanism of eukaryotic translation initiation and principles of its regulation. Nat Rev Mol Cell Biol. 2010;11:113–127.
   PubMed Web of Science ®Google Scholar
• Harding HP, Zhang Y, Scheuner D, et al. Ppp1r15 gene knockout reveals an essential role for translation initiation factor 2 alpha (eIF2α) dephosphorylation in mammalian development. Proc Natl Acad Sci. 2009;106:1832–1837.
   PubMed Web of Science ®Google Scholar
• Harding HP, Novoa I, Zhang Y, et al. Regulated translation initiation controls stress-induced gene expression in mammalian cells. Mol Cell. 2000;6:1099–1108.
   PubMed Web of Science ®Google Scholar
• Sano R, Reed JC. ER stress-induced cell death mechanisms. Biochim Biophys Acta BBA - Mol Cell Res. 2013;1833:3460–3470.
   PubMed Web of Science ®Google Scholar
• Schröder M, Kaufman RJ. ER stress and the unfolded protein response. Mutat Res Mol Mech Mutagen. 2005;569:29–63.
   PubMed Web of Science ®Google Scholar
• Robbins SL, Kumar V, Cotran RS. Pathologic basis of disease. 8th ed. Philadelphia, PA: Saunders/Elsevier; 2010; p. 1–28.
   Google Scholar
• Boyce M, Bryant KFJousse C, et al. A selective inhibitor of eif2alpha dephosphorylation protects cells from er stress. Science. 2005;307:935–939.
   PubMed Web of Science ®Google Scholar
• Dong B, Zhou H, Han C, et al. Ischemia/reperfusion-induced CHOP expression promotes apoptosis and impairs renal function recovery: the role of acidosis and GPR4. PloS One. 2014;9:e110944.
   PubMed Web of Science ®Google Scholar
• Debout A, Foucher Y, Trébern-Launay K, et al. Each additional hour of cold ischemia time significantly increases the risk of graft failure and mortality following renal transplantation. Kidney Int. 2015;87:343–349.
   PubMed Web of Science ®Google Scholar
• Saxena S, Cabuy E, Caroni P. A role for motoneuron subtype-selective ER stress in disease manifestations of FALS mice. Nat Neurosci. 2009;12:627–636.
   PubMed Web of Science ®Google Scholar
• Colla E, Coune P, Liu Y, et al. Endoplasmic reticulum stress is important for the manifestations of α-synucleinopathy in vivo. J Neurosci Off J Soc Neurosci. 2012;32:3306–3320.
   PubMed Web of Science ®Google Scholar
• Pandey VK, Mathur A, Khan MF, et al. Activation of PERK-eIF2α-ATF4 pathway contributes to diabetic hepatotoxicity: attenuation of ER stress by Morin. Cell Signal. 2019. DOI:10.1016/j.cellsig.2019.03.008.
   Web of Science ®Google Scholar
• Sidrauski C, McGeachy AM, Ingolia NT, et al. The small molecule ISRIB reverses the effects of eIF2α phosphorylation on translation and stress granule assembly. ELife. 2015;4. doi:10.7554/eLife.05033.
   Web of Science ®Google Scholar
• Wang L, Popko B, Tixier E, et al. Guanabenz, which enhances the unfolded protein response, ameliorates mutant SOD1-induced amyotrophic lateral sclerosis. Neurobiol Dis. 2014;71:317–324.
   PubMed Web of Science ®Google Scholar
• Das I, Krzyzosiak A, Schneider K, et al. Preventing proteostasis diseases by selective inhibition of a phosphatase regulatory subunit. Science. 2015;348:239–242.
   PubMed Web of Science ®Google Scholar
• Volkmann K, Lucas JL, Vuga D, et al. Potent and selective inhibitors of the inositol-requiring enzyme 1 endoribonuclease. J Biol Chem. 2011;286:12743–12755.
   PubMed Web of Science ®Google Scholar
• Papandreou I, Denko NC, Olson M, et al. Identification of an Ire1alpha endonuclease specific inhibitor with cytotoxic activity against human multiple myeloma. Blood. 2011;117:1311–1314.
   PubMed Web of Science ®Google Scholar
• Mimura N, Fulciniti M, Gorgun G, et al. Blockade of XBP1 splicing by inhibition of IRE1α is a promising therapeutic option in multiple myeloma. Blood. 2012;119:5772–5781.
   PubMed Web of Science ®Google Scholar
• Lee A-H, Iwakoshi NN, Glimcher LH. XBP-1 regulates a subset of endoplasmic reticulum resident chaperone genes in the unfolded protein response. Mol Cell Biol. 2003;23:7448–7459.
   PubMed Web of Science ®Google Scholar
• Cross BCS, Bond PJ, Sadowski PG, et al. The molecular basis for selective inhibition of unconventional mRNA splicing by an IRE1-binding small molecule. Proc Natl Acad Sci U S A. 2012;109:E869–878.
   PubMed Web of Science ®Google Scholar
• Wang L, Perera BGK, Hari SB, et al. Divergent allosteric control of the IRE1α endoribonuclease using kinase inhibitors. Nat Chem Biol. 2012;8:982–989.
   PubMed Web of Science ®Google Scholar
• Ali MMU, Bagratuni T, Davenport EL, et al. Structure of the Ire1 autophosphorylation complex and implications for the unfolded protein response. Embo J. 2011;30:894–905.
   PubMed Web of Science ®Google Scholar
• Jha BK, Polyakova I, Kessler P, et al. Inhibition of RNase L and RNA-dependent protein kinase (PKR) by sunitinib impairs antiviral innate immunity. J Biol Chem. 2011;286:26319–26326.
   PubMed Web of Science ®Google Scholar
• Ghosh R, Wang L, Wang ES, et al. Allosteric inhibition of the IRE1α RNase preserves cell viability and function during endoplasmic reticulum stress. Cell. 2014;158:534–548.
   PubMed Web of Science ®Google Scholar
• Ri M, Tashiro E, Oikawa D, et al. Identification of Toyocamycin, an agent cytotoxic for multiple myeloma cells, as a potent inhibitor of ER stress-induced XBP1 mRNA splicing. Blood Cancer J. 2012;2:e79.
   PubMed Web of Science ®Google Scholar
• Kawamura T, Tashiro E, Shindo K, et al. SAR study of a novel triene-ansamycin group compound, quinotrierixin, and related compounds, as inhibitors of ER stress-induced XBP1 activation. J Antibiot (Tokyo). 2008;61:312–317.
   PubMed Web of Science ®Google Scholar
• Gallagher CM, Garri C, Cain EL, et al. Ceapins are a new class of unfolded protein response inhibitors, selectively targeting the ATF6α branch. ELife. 2016;5. doi:10.7554/eLife.11878.
   Web of Science ®Google Scholar
• Kim D-S, Ha K-C, Kwon D-Y, et al. Kaempferol protects ischemia/reperfusion-induced cardiac damage through the regulation of endoplasmic reticulum stress. Immunopharmacol Immunotoxicol. 2008;30:257–270.
   PubMed Web of Science ®Google Scholar
• Bu L-J, Yu H-Q, Fan -L-L, et al. Melatonin, a novel selective ATF-6 inhibitor, induces human hepatoma cell apoptosis through COX-2 downregulation. World J Gastroenterol. 2017;23:986–998.
   PubMed Web of Science ®Google Scholar
• Mukhopadhyay P, Horváth B, Zsengellėr Z, et al. Mitochondrial reactive oxygen species generation triggers inflammatory response and tissue injury associated with hepatic ischemia-reperfusion: therapeutic potential of mitochondrially targeted antioxidants. Free Radic Biol Med. 2012;53:1123–1138.
   PubMed Web of Science ®Google Scholar
• Cohen JJ. Relationship between energy requirements for Na+ reabsorption and other renal functions. Kidney Int. 1986;29:32–40.
   PubMed Web of Science ®Google Scholar
• Chevalier RL. The proximal tubule is the primary target of injury and progression of kidney disease: role of the glomerulotubular junction. Am J Physiol - Ren Physiol. 2016;311:F145–61.
   PubMed Web of Science ®Google Scholar
• Forman HJ, Maiorino M, Ursini F. Signaling functions of reactive oxygen species. Biochemistry. 2010;49:835–842.
   PubMed Web of Science ®Google Scholar
• Schieber M, Chandel NS. ROS function in redox signaling and oxidative stress. Curr Biol CB. 2014;24:R453–62.
   PubMed Web of Science ®Google Scholar
• Hoeksma D, Rebolledo RA, Hottenrott M, et al. Inadequate antioxidative responses in kidneys of brain-dead rats. Transplantation. 2017;101:746–753.
   PubMed Web of Science ®Google Scholar
• Vance JE. Phospholipid synthesis in a membrane fraction associated with mitochondria. J Biol Chem. 1990;265:7248–7256.
   PubMed Web of Science ®Google Scholar
• Raturi A, Simmen T. Where the endoplasmic reticulum and the mitochondrion tie the knot: the mitochondria-associated membrane (MAM). Biochim Biophys Acta. 2013;1833:213–224.
   PubMed Web of Science ®Google Scholar
• van Vliet AR, Agostinis P. Mitochondria-Associated Membranes and ER Stress. Curr Top Microbiol Immunol. 2018;414:73–102.
   PubMed Web of Science ®Google Scholar
• Morita M, Gravel S-P, Hulea L, et al. mTOR coordinates protein synthesis, mitochondrial activity and proliferation. Cell Cycle. 2015;14:473–480.
   PubMed Web of Science ®Google Scholar
• Lebeau J, Saunders JM, Moraes VWR, et al. The PERK arm of the unfolded protein response regulates mitochondrial morphology during acute endoplasmic reticulum stress. Cell Rep. 2018;22:2827–2836.
   PubMed Web of Science ®Google Scholar
• Szeto HH. Pharmacologic approaches to improve mitochondrial function in AKI and CKD. J Am Soc Nephrol JASN. 2017;28:2856–2865. .
   PubMed Web of Science ®Google Scholar
• Dare AJ, Bolton EA, Pettigrew GJ, et al. Protection against renal ischemia-reperfusion injury in vivo by the mitochondria targeted antioxidant MitoQ. Redox Biol. 2015;5:163–168.
   PubMed Web of Science ®Google Scholar
• Liang HL, Sedlic F, Bosnjak Z, et al. SOD1 and MitoTEMPO partially prevent mitochondrial permeability transition pore opening, necrosis, and mitochondrial apoptosis after ATP depletion recovery. Free Radic Biol Med. 2010;49:1550–1560.
   PubMed Web of Science ®Google Scholar
• Jankauskas SS, Andrianova NV, Alieva IB, et al. Dysfunction of kidney endothelium after ischemia/reperfusion and its prevention by mitochondria-targeted antioxidant. Biochem Biokhimiia. 2016;81:1538–1548.
   PubMed Web of Science ®Google Scholar
• Szeto HH, Liu S, Soong Y, et al. Mitochondria protection after acute ischemia prevents prolonged upregulation of IL-1β and IL-18 and arrests CKD. J Am Soc Nephrol JASN. 2017;28:1437–1449.
   PubMed Web of Science ®Google Scholar
• Erpicum P, Rowart P, Defraigne J-O, et al. What we need to know about lipid-associated injury in case of renal ischemia-reperfusion. Am J Physiol Renal Physiol. 2018;315:F1714–9.
   PubMed Web of Science ®Google Scholar
• Singh AP, Singh N, Bedi PMS. Pioglitazone ameliorates renal ischemia reperfusion injury through NMDA receptor antagonism in rats. Mol Cell Biochem. 2016;417:111–118.
   PubMed Web of Science ®Google Scholar
• Cameron RB, Gibbs WS, Miller SR, et al. Proximal tubule β2-adrenergic receptor mediates formoterol-induced recovery of mitochondrial and renal function after ischemia-reperfusion injury. J Pharmacol Exp Ther. 2019;369:173–180.
   PubMed Web of Science ®Google Scholar
• Rasbach KA, Funk JA, Jayavelu T, et al. 5-hydroxytryptamine receptor stimulation of mitochondrial biogenesis. J Pharmacol Exp Ther. 2010;332:632–639.
   PubMed Web of Science ®Google Scholar
• Lemoine S, Pillot B, Augeul L, et al. Dose and timing of injections for effective cyclosporine A pretreatment before renal ischemia reperfusion in mice. PloS One. 2017;12:e0182358.
   PubMed Web of Science ®Google Scholar
• Sumida M, Doi K, Ogasawara E, et al. Regulation of mitochondrial dynamics by dynamin-related protein-1 in acute cardiorenal syndrome. J Am Soc Nephrol JASN. 2015;26:2378–2387.
   PubMed Web of Science ®Google Scholar
• McCord JM. Oxygen-derived free radicals in postischemic tissue injury. N Engl J Med. 1985;312:159–163.
   PubMed Web of Science ®Google Scholar
• Land W, Schneeberger H, Schleibner S, et al. The beneficial effect of human recombinant superoxide dismutase on acute and chronic rejection events in recipients of cadaveric renal transplants. Transplantation. 1994;57:211–217.
   PubMed Web of Science ®Google Scholar
• Mundt HM, Yard BA, Krämer BK, et al. Optimized donor management and organ preservation before kidney transplantation. Transpl Int Off J Eur Soc Organ Transplant. 2016;29:974–984.
   PubMed Web of Science ®Google Scholar
• Orban J-C, Quintard H, Cassuto E, et al. Effect of N-acetylcysteine pretreatment of deceased organ donors on renal allograft function: a randomized controlled trial. Transplantation. 2015;99:746–753.
   PubMed Web of Science ®Google Scholar
• Jafari A, Khatami M-R, Dashti-Khavidaki S, et al. Protective effects of L-carnitine against delayed graft function in kidney transplant recipients: A pilot, randomized, double-blinded, placebo-controlled clinical trial. J Ren Nutr Off J Counc Ren Nutr Natl Kidney Found. 2017;27:113–126.
   Google Scholar
• Ambrosi N, Arrosagaray V, Guerrieri D, et al. α-lipoic acid protects against ischemia-reperfusion injury in simultaneous kidney-pancreas transplantation. Transplantation. 2016;100:908–915.
   PubMed Web of Science ®Google Scholar
• Thuillier R, Allain G, Giraud S, et al. Cyclodextrin curcumin formulation improves outcome in a preclinical pig model of marginal kidney transplantation. Am J Transplant Off J Am Soc Transplant Am Soc Transpl Surg. 2014;14:1073–1083.
   PubMed Web of Science ®Google Scholar
• Bolisetty S, Zarjou A, Agarwal A. Heme oxygenase 1 as a therapeutic target in acute kidney injury. Am J Kidney Dis Off J Natl Kidney Found. 2017;69:531–545.
   PubMed Web of Science ®Google Scholar
• Lan R, Geng H, Singha PK, et al. Mitochondrial pathology and glycolytic shift during proximal tubule atrophy after ischemic AKI. J Am Soc Nephrol. 2016;27:3356–3367.
   PubMed Web of Science ®Google Scholar
• Wei Q, Xiao X, Fogle P, et al. Changes in metabolic profiles during acute kidney injury and recovery following ischemia/reperfusion. PloS One. 2014;9:e106647.
   PubMed Web of Science ®Google Scholar
• Vigne P, Frelin C. The role of polyamines in protein-dependent hypoxic tolerance of Drosophila. BMC Physiol. 2008;8:22.
   PubMedGoogle Scholar
• Park MH, Nishimura K, Zanelli CF, et al. Functional significance of eIF5A and its hypusine modification in eukaryotes. Amino Acids. 2010;38:491–500.
   PubMed Web of Science ®Google Scholar
• Melis N, Rubera I, Cougnon M, et al. Targeting eIF5A hypusination prevents anoxic cell death through mitochondrial silencing and improves kidney transplant outcome. J Am Soc Nephrol JASN. 2017;28:811–822. .
   PubMed Web of Science ®Google Scholar
• Drury ER, Zsengeller ZK, Stillman IE, et al. Renal PGC1α may be associated with recovery after delayed graft function. Nephron. 2018;138:303–309.
   PubMed Web of Science ®Google Scholar
• Chen S-D, Yang D-I, Lin T-K, et al. Roles of oxidative stress, apoptosis, PGC-1α and mitochondrial biogenesis in cerebral ischemia. Int J Mol Sci. 2011;12:7199–7215.
   PubMed Web of Science ®Google Scholar
• Tarjus A, Amador C, Michea L, et al. Vascular mineralocorticoid receptor and blood pressure regulation. Curr Opin Pharmacol. 2015;21:138–144.
   PubMed Web of Science ®Google Scholar
• Messaoudi S, Azibani F, Delcayre C, et al. Aldosterone, mineralocorticoid receptor, and heart failure. Mol Cell Endocrinol. 2012;350:266–272.
   PubMed Web of Science ®Google Scholar
• Pitt B, Remme W, Zannad F, et al. Eplerenone, a selective aldosterone blocker, in patients with left ventricular dysfunction after myocardial infarction. N Engl J Med. 2003;348:1309–1321.
   PubMed Web of Science ®Google Scholar
• Zannad F, McMurray JJV, Krum H, et al. Eplerenone in patients with systolic heart failure and mild symptoms. N Engl J Med. 2011;364:11–21.
   PubMed Web of Science ®Google Scholar
• Bertocchio J-P, Warnock DG, Jaisser F. Mineralocorticoid receptor activation and blockade: an emerging paradigm in chronic kidney disease. Kidney Int. 2011;79:1051–1060.
   PubMed Web of Science ®Google Scholar
• Maïga S, Allain G, Hauet T, et al. Renal auto-transplantation promotes cortical microvascular network remodeling in a preclinical porcine model. PloS One. 2017;12:e0181067.
   PubMed Web of Science ®Google Scholar
• Griol-Charhbili V, Fassot C, Messaoudi S, et al. Epidermal growth factor receptor mediates the vascular dysfunction but not the remodeling induced by aldosterone/salt. Hypertens Dallas Tex. 1979[2011];57:238–244.
   Google Scholar
• Nguyen Dinh Cat A, Griol-Charhbili V, Loufrani L, et al. The endothelial mineralocorticoid receptor regulates vasoconstrictor tone and blood pressure. FASEB J Off Publ Fed Am Soc Exp Biol. 2010;24:2454–2463.
   PubMed Web of Science ®Google Scholar
• Galmiche G, Pizard A, Gueret A, et al. Smooth muscle cell mineralocorticoid receptors are mandatory for aldosterone-salt to induce vascular stiffness. Hypertens Dallas Tex. 1979[2014];63:520–526.
   Google Scholar
• Amador CA, Bertocchio J-P, Andre-Gregoire G, et al. Deletion of mineralocorticoid receptors in smooth muscle cells blunts renal vascular resistance following acute cyclosporine administration. Kidney Int. 2016;89:354–362.
   PubMed Web of Science ®Google Scholar
• Usher MG, Duan SZ, Ivaschenko CY, et al. Myeloid mineralocorticoid receptor controls macrophage polarization and cardiovascular hypertrophy and remodeling in mice. J Clin Invest. 2010;120:3350–3364.
   PubMed Web of Science ®Google Scholar
• Huang LL, Nikolic-Paterson DJ, Han Y, et al. Myeloid mineralocorticoid receptor activation contributes to progressive kidney disease. J Am Soc Nephrol JASN. 2014;25:2231–2240.
   PubMed Web of Science ®Google Scholar
• Pitt B, Kober L, Ponikowski P, et al. Safety and tolerability of the novel non-steroidal mineralocorticoid receptor antagonist BAY 94-8862 in patients with chronic heart failure and mild or moderate chronic kidney disease: a randomized, double-blind trial. Eur Heart J. 2013;34:2453–2463.
   PubMed Web of Science ®Google Scholar
• Bertocchio J-P, Barbe C, Lavaud S, et al. Safety of eplerenone for kidney-transplant recipients with impaired renal function and receiving cyclosporine A. PloS One. 2016;11:e0153635.
   PubMed Web of Science ®Google Scholar
• Girerd S, Frimat L, Ducloux D, et al. EPURE transplant (Eplerenone in Patients Undergoing Renal Transplant) study: study protocol for a randomized controlled trial. Trials. 2018;19:595.
   PubMed Web of Science ®Google Scholar
• Mejía-Vilet JM, Ramírez V, Cruz C, et al. Renal ischemia-reperfusion injury is prevented by the mineralocorticoid receptor blocker spironolactone. Am J Physiol Renal Physiol. 2007;293:F78–86.
   PubMed Web of Science ®Google Scholar
• Sánchez-Pozos K, Barrera-Chimal J, Garzón-Muvdi J, et al. Recovery from ischemic acute kidney injury by spironolactone administration. Nephrol Dial Transplant Off Publ Eur Dial Transpl Assoc - Eur Ren Assoc. 2012;27:3160–3169.
   PubMed Web of Science ®Google Scholar
• Barrera-Chimal J, Pérez-Villalva R, Rodríguez-Romo R, et al. Spironolactone prevents chronic kidney disease caused by ischemic acute kidney injury. Kidney Int. 2013;83:93–103.
   PubMed Web of Science ®Google Scholar
• Barrera-Chimal J, Prince S, Fadel F, et al. Sulfenic acid modification of endothelin B receptor is responsible for the benefit of a nonsteroidal mineralocorticoid receptor antagonist in renal ischemia. J Am Soc Nephrol JASN. 2016;27:398–404. .
   PubMed Web of Science ®Google Scholar
• Barrera-Chimal J, Estrela GR, Lechner SM, et al. The myeloid mineralocorticoid receptor controls inflammatory and fibrotic responses after renal injury via macrophage interleukin-4 receptor signaling. Kidney Int. 2018;93:1344–1355. .
   PubMed Web of Science ®Google Scholar
• Barrera-Chimal J, André-Grégoire G, Nguyen Dinh Cat A, et al. Benefit of mineralocorticoid receptor antagonism in AKI: role of vascular smooth muscle rac1. J Am Soc Nephrol JASN. 2017;28:1216–1226.
   PubMed Web of Science ®Google Scholar
• Ohtake T, Kobayashi S, Slavin S, et al. Human peripheral blood mononuclear cells incubated in vasculogenic conditioning medium dramatically improve ischemia/reperfusion acute kidney injury in Mice. Cell Transplant. 2018;963689717753186. doi:10.1177/0963689717753186.
   Web of Science ®Google Scholar
• Liang C-J, Shen W-C, Chang F-B, et al. Endothelial progenitor cells derived from wharton’s jelly of human umbilical cord attenuate ischemic acute kidney injury by increasing vascularization and decreasing apoptosis, inflammation, and fibrosis. Cell Transplant. 2015;24:1363–1377.
   PubMed Web of Science ®Google Scholar
• Yuan X, Li D, Chen X, et al. Extracellular vesicles from human-induced pluripotent stem cell-derived mesenchymal stromal cells (hiPSC-MSCs) protect against renal ischemia/reperfusion injury via delivering specificity protein (SP1) and transcriptional activating of sphingosine kinase 1 and inhibiting necroptosis. Cell Death Dis. 2017;8:3200.
   PubMed Web of Science ®Google Scholar
• Tarng D-C, Tseng W-C, Lee P-Y, et al. Induced pluripotent stem cell-derived conditioned medium attenuates acute kidney injury by downregulating the oxidative stress-related pathway in ischemia-reperfusion rats. Cell Transplant. 2016;25:517–530.
   PubMed Web of Science ®Google Scholar
• Zhou L, Xu L, Shen J, et al. Preischemic administration of nonexpanded adipose stromal vascular fraction attenuates acute renal ischemia/reperfusion injury and fibrosis. Stem Cells Transl Med. 2016;5:1277–1288.
   PubMed Web of Science ®Google Scholar
• Zhou L, Song Q, Shen J, et al. Comparison of human adipose stromal vascular fraction and adipose-derived mesenchymal stem cells for the attenuation of acute renal ischemia/reperfusion injury. Sci Rep. 2017;7:44058.
   PubMed Web of Science ®Google Scholar
• Erpicum P, Rowart P, Poma L, et al. Administration of mesenchymal stromal cells before renal ischemia/reperfusion attenuates kidney injury and may modulate renal lipid metabolism in rats. Sci Rep. 2017;7:8687.
   PubMed Web of Science ®Google Scholar
• Baulier E, Favreau F, Le Corf A, et al. Amniotic fluid-derived mesenchymal stem cells prevent fibrosis and preserve renal function in a preclinical porcine model of kidney transplantation. Stem Cells Transl Med. 2014;3:809–820. .
   PubMed Web of Science ®Google Scholar
• Cai J, Yu X, Xu R, et al. Maximum efficacy of mesenchymal stem cells in rat model of renal ischemia-reperfusion injury: renal artery administration with optimal numbers. PloS One. 2014;9:e92347.
   PubMed Web of Science ®Google Scholar
• Mori Da Cunha MGMC, Zia S, Beckmann DV, et al. Vascular endothelial growth factor up-regulation in human amniotic fluid stem cell enhances nephroprotection after ischemia-reperfusion injury in the rat. Crit Care Med. 2017;45:e86–96.
   PubMedGoogle Scholar
• Xue J, Qin Z, Li X, et al. Protective effects of ischemic preconditioning-mediated homing of endothelial progenitor cells on renal acute ischemia and reperfusion injury in male rats. Ann Transplant. 2017;22:66–74.
   PubMed Web of Science ®Google Scholar
• Wang J, Wang F, Wang Z, et al. Protective effect of GDNF-engineered amniotic fluid-derived stem cells on the renal ischaemia reperfusion injury in vitro. Cell Prolif. 2018;51:e12400.
   PubMed Web of Science ®Google Scholar
• Aghajani Nargesi A, Lerman LO, Eirin A. Mesenchymal stem cell-derived extracellular vesicles for kidney repair: current status and looming challenges. Stem Cell Res Ther. 2017;8:273.
   PubMed Web of Science ®Google Scholar
• Ranghino A, Bruno S, Bussolati B, et al. The effects of glomerular and tubular renal progenitors and derived extracellular vesicles on recovery from acute kidney injury. Stem Cell Res Ther. 2017;8:24.
   PubMed Web of Science ®Google Scholar
• Dominguez JH, Liu Y, Gao H, et al. Renal tubular cell-derived extracellular vesicles accelerate the recovery of established renal ischemia reperfusion injury. J Am Soc Nephrol JASN. 2017;28:3533–3544.
   PubMed Web of Science ®Google Scholar
• Gu D, Zou X, Ju G, et al. Mesenchymal stromal cells derived extracellular vesicles ameliorate acute renal ischemia reperfusion injury by inhibition of mitochondrial fission through miR-30. Stem Cells Int. 2016;2016:2093940.
   PubMed Web of Science ®Google Scholar
• Zhang G, Zou X, Miao S, et al. The anti-oxidative role of micro-vesicles derived from human Wharton-Jelly mesenchymal stromal cells through NOX2/gp91(phox) suppression in alleviating renal ischemia-reperfusion injury in rats. PloS One. 2014;9:e92129.
   PubMed Web of Science ®Google Scholar
• Lin K-C, Yip H-K, Shao P-L, et al. Combination of adipose-derived mesenchymal stem cells (ADMSC) and ADMSC-derived exosomes for protecting kidney from acute ischemia-reperfusion injury. Int J Cardiol. 2016;216:173–185.
   PubMed Web of Science ®Google Scholar
• Bai M, Zhang L, Fu B, et al. IL-17A improves the efficacy of mesenchymal stem cells in ischemic-reperfusion renal injury by increasing Treg percentages by the COX-2/PGE2 pathway. Kidney Int. 2018;93:814–825.
   PubMed Web of Science ®Google Scholar
• Zhang W, Liu L, Huo Y, et al. Hypoxia-pretreated human MSCs attenuate acute kidney injury through enhanced angiogenic and antioxidative capacities. BioMed Res Int. 2014;2014:462472.
   PubMed Web of Science ®Google Scholar
• Hussein AM, Barakat N, Awadalla A, et al. Modulation of renal ischemia/reperfusion in rats by a combination of ischemic preconditioning and adipose-derived mesenchymal stem cells (ADMSCs). Can J Physiol Pharmacol. 2016;94:936–946.
   PubMed Web of Science ®Google Scholar
• Lee Y, Kim M, Han J, et al. MicroRNA genes are transcribed by RNA polymerase II. Embo J. 2004;23:4051–4060.
   PubMed Web of Science ®Google Scholar
• Godwin JG, Ge X, Stephan K, et al. Identification of a microRNA signature of renal ischemia reperfusion injury. Proc Natl Acad Sci U S A. 2010;107:14339–14344.
   PubMed Web of Science ®Google Scholar
• Kaucsár T, Révész C, Godó M, et al. Activation of the miR-17 family and miR-21 during murine kidney ischemia-reperfusion injury. Nucleic Acid Ther. 2013;23:344–354.
   PubMed Web of Science ®Google Scholar
• Narayanan SV, Dave KR, Perez-Pinzon MA. Ischemic preconditioning and clinical scenarios. Curr Opin Neurol. 2013;26:1–7.
   PubMed Web of Science ®Google Scholar
• Xu X, Kriegel AJ, Liu Y, et al. Delayed ischemic preconditioning contributes to renal protection by upregulation of miR-21. Kidney Int. 2012;82:1167–1175.
   PubMed Web of Science ®Google Scholar
• Yu S-Y, Tang L, Zhou S-H. Long noncoding RNAs: new players in ischaemia-reperfusion injury. Heart Lung Circ. 2018;27:322–332.
   PubMed Web of Science ®Google Scholar
• Kölling M, Genschel C, Kaucsar T, et al. Hypoxia-induced long non-coding RNA Malat1 is dispensable for renal ischemia/reperfusion-injury. Sci Rep. 2018;8. doi:10.1038/s41598-018-21720-3.
   PubMedGoogle Scholar
• Chatauret N, Thuillier R, Hauet T. Preservation strategies to reduce ischemic injury in kidney transplantation: pharmacological and genetic approaches. Curr Opin Organ Transpl. 2011;16:180–187.
   PubMed Web of Science ®Google Scholar
• Jiang S-J, Li W, An W. Adenoviral gene transfer of hepatic stimulator substance confers resistance against hepatic ischemia-reperfusion injury by improving mitochondrial function. Hum Gene Ther. 2013;24:443–456.
   PubMed Web of Science ®Google Scholar
• Zhao Y-P, Li L, Ma J-P, et al. LXRalpha gene downregulation by lentiviral-based RNA interference enhances liver function after fatty liver transplantation in rats. Hepatobiliary Pancreat Dis Int HBPD INT. 2015;14:386–393.
   PubMed Web of Science ®Google Scholar
• Del Sorbo L, Costamagna A, Muraca G, et al. Intratracheal administration of small interfering RNA targeting fas reduces lung ischemia-reperfusion injury. Crit Care Med. 2016;44:e604–613.
   PubMed Web of Science ®Google Scholar
• Hou L, Chen G, Feng B, et al. Small interfering RNA targeting TNF-α gene significantly attenuates renal ischemia-reperfusion injury in mice. J Huazhong Univ Sci Technol Med Sci Hua Zhong Ke Ji Xue Xue Bao Yi Xue Ying Wen Ban Huazhong Keji Daxue Xuebao Yixue Yingdewen Ban. 2016;36:634–638.
   PubMedGoogle Scholar
• Zheng X, Zang G, Jiang J, et al. Attenuating ischemia-reperfusion injury in kidney transplantation by perfusing donor organs with siRNA cocktail solution. Transplantation. 2016;100:743–752. .
   PubMed Web of Science ®Google Scholar
• de Ramon L, Jarque M, Ripoll E, et al. RNAi-based therapy in experimental ischemia-reperfusion injury. The New Targets Curr Pharm Des. 2016;22:4651–4657.
   PubMed Web of Science ®Google Scholar
• Yoshitomi T, Hirayama A, Nagasaki Y. The ROS scavenging and renal protective effects of pH-responsive nitroxide radical-containing nanoparticles. Biomaterials. 2011;32:8021–8028.
   PubMed Web of Science ®Google Scholar
• Jedrzejczyk D, Gendaszewska-Darmach E, Pawlowska R, et al. Designing synthetic RNA for delivery by nanoparticles. J Phys Condens Matter Inst Phys J. 2017;29:123001.
   PubMed Web of Science ®Google Scholar
• Zuk A, Palevsky PM, Fried L, et al. Overcoming translational barriers in acute kidney injury: A report from an NIDDK workshop. Clin J Am Soc Nephrol CJASN. 2018;13:1113–1123.
   Google Scholar